Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has entered into an exclusive agreement with the Wellcome Trust Sanger Institute to manufacture and distribute the Sanger Institute's ...
FRANKFURT, GERMANY, December 11, 2024 /EINPresswire.com/ -- Vivlion GmbH, a leader in CRISPR-based screening technologies, today announced the launch of its new ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results